Oncternal Therapeutics
1 follower
‌
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.
Industries
Headquarters
Employees
Links
Org chart
James Breitmeyer
President & CEO
James Breitmeyer
Collapse
Rajesh Krishnan
Chief Scientific Officer And Chief Technical Officer
Salim Yazji
Chief Medical Officer
Chase Leavitt
General Counsel & Corporate Secretary
Pablo Urbaneja
Senior Vice President, Corporate Development
Anita Wiseth
Senior Vice President, HR
Angela Pietrofeso
Vice President, Clinical Development Operations
Mary Breitmeyer
Vp, Technical Operations & Alliance Management
